Hao Zeng
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Urology top 5%
Papers in
-
- Prostate Cancer Diagnosis and Treatment 26
- Prostate Cancer Treatment and Research 22
- Renal cell carcinoma treatment 16
-
- Renal and related cancers 5
- Co-authors
- Pengfei Shen (46 shared papers)Philip A. Rea (1 shared paper)Geoffrey Liu (1 shared paper)Gary D. Kruh (1 shared paper)Guangxi Sun (39 shared papers)Jinge Zhao (30 shared papers)Ni Chen (20 shared papers)Junru Chen (35 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Frontiers in Oncology (6 papers)The Prostate (5 papers)Annals of Oncology (5 papers)Cancer Management and Research (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Hao Zeng
101 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 684
- Urology 97
- Oncology 341
- Rheumatology 181
- Cancer Research 99
Countries citing papers authored by Hao Zeng
This map shows the geographic impact of Hao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Zeng more than expected).
Fields of papers citing papers by Hao Zeng
This network shows the impact of papers produced by Hao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Zeng. The network helps show where Hao Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transport of amphipathic anions by human multidrug resistance protein 3. | 2000 | 205 |
| 2 | 2020 | 115 | |
| 3 | 2011 | 104 | |
| 4 | 2009 | 63 | |
| 5 | 2019 | 55 | |
| 6 | 2014 | 50 | |
| 7 | 2015 | 40 | |
| 8 | 2015 | 40 | |
| 9 | 2012 | 39 | |
| 10 | 2016 | 39 | |
| 11 | 2020 | 32 | |
| 12 | 2017 | 29 | |
| 13 | 2023 | 28 | |
| 14 | 2020 | 27 | |
| 15 | SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway. | 2015 | 27 |
| 16 | 2019 | 23 | |
| 17 | 2019 | 23 | |
| 18 | 2019 | 21 | |
| 19 | 2015 | 20 | |
| 20 | 2019 | 20 |
About Hao Zeng
Hao Zeng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Cancer Research, having authored 114 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (26 papers), Prostate Cancer Treatment and Research (22 papers), Renal cell carcinoma treatment (16 papers), Bladder and Urothelial Cancer Treatments (9 papers), Cancer, Lipids, and Metabolism (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Renal and related cancers (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (684 citations), Urology (97 citations), Oncology (341 citations), Rheumatology (181 citations) and Cancer Research (99 citations). Hao Zeng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Pengfei Shen, Philip A. Rea, Geoffrey Liu, Gary D. Kruh, Guangxi Sun, Jinge Zhao, Ni Chen, Junru Chen, Qiang Wei and Xiang Li. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, The Prostate, Annals of Oncology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.